Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors

被引:34
作者
De la Fuente, L
Bravo, MJ
Barrio, G
Parras, F
Suárez, M
Rodés, A
Noguer, I
机构
[1] Inst Salud Carlos III, Ctr Nacl Epidemiol, Madrid 28071, Spain
[2] Ctr Univ Salud Publ, Madrid, Spain
关键词
D O I
10.1086/377562
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In Spain, similar to 10 years passed between the time when human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome ( AIDS) harm-reduction programs should have been developed with sufficient coverage to have an optimum impact on public health ( before the HIV/AIDS epidemic's explosion in 1984) and the date of their actual implementation. This delay yielded an enormous cost for the country. The introduction of the virus in drug injector networks during a period of widespread diffusion of heroin injection and the lack of political awareness of the growing problem were 2 important factors that contributed to the important diffusion of the HIV infection among Spanish injection drug users. Lessons can be learned that may be of great interest in countries or territories facing similar challenges now and in the future.
引用
收藏
页码:S410 / S415
页数:6
相关论文
共 27 条
[1]  
*ADV COUNC MIS DRU, 1988, AIDS DRUGS MIS 1
[2]  
AGUILAR E, 1987, PROBLEMAS MEDICOS AD
[3]  
[Anonymous], HEROIN ADDICTION DRU
[4]   Drug use and the spread of HIV/AIDS in South America and the Caribbean [J].
Bastos, FI ;
Strathdee, SA ;
Derrico, M ;
Pina, MD .
DRUGS-EDUCATION PREVENTION AND POLICY, 1999, 6 (01) :29-49
[5]  
BUNING EC, 1991, INT J ADDICT, V26, P1303
[6]   Trends in the number of HIV infected persons and AIDS cases in Spain: 1980-1998 [J].
Castilla, J ;
de la Fuente, L .
MEDICINA CLINICA, 2000, 115 (03) :85-89
[7]  
COSTIGAN G, 2002, REVISITING HIDDEN EP
[8]   The first hit: Circumstances surrounding initiation into injecting [J].
Crofts, N ;
Louie, R ;
Rosenthal, D ;
Jolley, D .
ADDICTION, 1996, 91 (08) :1187-1196
[9]  
de la Fuente L, 1998, ADDICTION, V93, P444
[10]   MAINTAINING LOW HIV SEROPREVALENCE IN POPULATIONS OF INJECTING DRUG-USERS [J].
DESJARLAIS, DC ;
HAGAN, H ;
FRIEDMAN, SR ;
FRIEDMANN, P ;
GOLDBERG, D ;
FRISCHER, M ;
GREEN, S ;
TUNVING, K ;
LJUNGBERG, B ;
WODAK, A ;
ROSS, M ;
PURCHASE, D ;
MILLSON, ME ;
MYERS, T .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (15) :1226-1231